Evidence map›Paper›PMID 42183194›Full record

ArticleFrontiers in immunology2026

Development and validation of an interpretable prediction model using spatial patterns of tumor-infiltrating lymphocytes in H&E-stained whole-slide images for immune subtyping of lung adenocarcinoma.

Xia Li, Hai-Zhen Qin, Jing-Yu Wei, Kang-Lai Wei, Zhao-Quan Huang

Abstract readValidation Study
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xia LiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Hai-Zhen QinDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Jing-Yu WeiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Kang-Lai WeiDepartment of Pathology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Zhao-Quan HuangDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop an interpretable prediction model for lung adenocarcinoma immune subtyping by quantifying spatial distribution patterns of tumor-infiltrating lymphocytes in H&E whole-slide images, providing a computational tool for tumor immune microenvironment evaluation. Methods: Immune subtyping was performed on the TCGA lung adenocarcinoma cohort using ssGSEA to quantify immune gene set activity, followed by hierarchical clustering and t-SNE visualization to stratify patients into high- and low-immunity subgroups. Immune cell infiltration was assessed using CIBERSORT, while tumor mutation burden and somatic mutation profiles were analyzed with maftools. Differential expression and functional enrichment analyses were conducted using GO and KEGG databases. In pathological image analysis, an automated annotation model optimized with study-specific data was employed to process whole-slide images. Immune subtype prediction criteria were established by quantifying spatial distribution features of tumor-infiltrating lymphocytes. The model's predictive performance was validated in both internal and external cohorts. Results: Transcriptomic analysis stratified 503 LUAD patients into high- and low-immunity subgroups. The high-immunity group exhibited elevated infiltration of CD8 Conclusion: This study establishes an interpretable immune subtype prediction model for LUAD based on TIL spatial distribution in H&E-stained sections. Through a modular design that integrates deep learning-based annotation with statistical classification, the model links morphological phenotypes to molecular immune subtypes while maintaining transparency and verifiability throughout the analytical workflow. This cost-effective and scalable tool offers potential value for assessing tumor immune status and guiding immunotherapy decision-making.

Indexed as

Adenocarcinoma of LungLung NeoplasmsLymphocytes, Tumor-InfiltratingBiomarkers, TumorGene Expression ProfilingHumansTumor MicroenvironmentBiomarkers, Tumorcomputational pathologyimmune subtypinginterpretable modellung adenocarcinomatumor-infiltrating lymphocytes

Identifiers

PMID42183194
PMCPMC13194154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.